Literature DB >> 16914359

Forensic considerations of missed diagnoses in trauma deaths.

B R Sharma1, Manisha Gupta, Sumedha Bangar, Virender Pal Singh.   

Abstract

Injuries missed at initial diagnoses or operations have the potential to cause disastrous complications in trauma patients. Understanding the etiology of unrecognized injuries is essential in minimizing its occurrence. For this purpose, we scrutinized the treatment and the autopsy records of the trauma deaths from 2000 to 2004 to determine the frequency, body regions, severity and causes of injuries that escaped recognition during the initial assessment, primary, secondary and tertiary surveys by the clinical team in patients who died of trauma. We also examined the accuracy of the cause of death as recorded on death certificates. The frequency of unrecognized injuries was found to be 11% in all trauma deaths. Abdomen (40%) and head (29%) were the more common regions of the body where injuries were frequently missed. System related errors (68%) and patient related factors (32%) were responsible for the injury remaining unrecognized. It was concluded that the injuries may be missed at any stage of the management of patients with major trauma and repeated assessments both clinical and radiological are mandatory not only to diminish the problem but to avoid litigation as well.

Entities:  

Mesh:

Year:  2006        PMID: 16914359     DOI: 10.1016/j.jcfm.2006.02.027

Source DB:  PubMed          Journal:  J Forensic Leg Med        ISSN: 1752-928X            Impact factor:   1.614


  2 in total

1.  Autopsy after traumatic death--a shifting paradigm.

Authors:  Timothy D Light; Nora A Royer; Joseph Zabell; Mark B Le; Timothy A Thomsen; Gerald P Kealey; Michel A Alpen; Marcus B Nashelsky
Journal:  J Surg Res       Date:  2009-08-07       Impact factor: 2.192

2.  Crashes involving motorised rickshaws in urban India: characteristics and injury patterns.

Authors:  Uli Schmucker; Rakhi Dandona; G Anil Kumar; Lalit Dandona
Journal:  Injury       Date:  2011-01       Impact factor: 2.586

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.